CDH10 and lung cancer: Similarly, higher expression of Cdh10 was associated with significantly worse post-progression survival (PPS, p < 1e-16) in gastric cancer datasets and progression free survival (PFS) in lung cancer patients, while lower expression levels of Tbc1d9 in gastric cancer and lung cancer patients resulted in better PPS and PFS, respectively (Figure 6D-E and Figure S7).